Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent bacterial vaginosis

P E Hay1

  • 1Department of Genitourinary Medicine, St. George's Hospital Medical School, London, United Kingdom.

Dermatologic Clinics
|January 19, 1999
PubMed
Summary
This summary is machine-generated.

Bacterial vaginosis (BV) causes fishy vaginal discharge and can recur frequently. Understanding BV triggers is key to better management beyond antibiotics, with research exploring Lactobacillus strains for vaginal flora restoration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Chlamydia related bacteria (Chlamydiales) in early pregnancy: community-based cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

Trichomonas vaginalis among multiethnic female UK students.

Sexually transmitted infections·2011
Same author

Prevalence of Neisseria gonorrhoeae infection in young women in South London.

Sexually transmitted infections·2008
Same author

Mycoplasma genitalium in chronic non-gonococcal urethritis.

International journal of STD & AIDS·2004
Same author

Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.

Clinical and experimental immunology·2003
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Microbiology
  • Gynecology
  • Infectious Diseases

Background:

  • Bacterial vaginosis (BV) is a prevalent condition characterized by malodorous vaginal discharge.
  • Frequent symptomatic recurrences of BV pose a significant management challenge.
  • Current understanding of BV onset and resolution triggers is limited, hindering effective treatment strategies.

Purpose of the Study:

  • To investigate novel therapeutic approaches for bacterial vaginosis (BV).
  • To explore the potential of restoring vaginal flora with cultured Lactobacillus strains.
  • To identify factors influencing the onset and resolution of BV for improved patient management.

Main Methods:

  • Review of current treatment modalities for BV, including antibiotic and antifungal therapies.

Related Experiment Videos

  • Examination of ongoing research into the use of Lactobacillus species for vaginal microbiome modulation.
  • Analysis of factors contributing to recurrent BV and potential trigger identification.

    • Main Results:

    • Current BV management relies heavily on repeated antibiotic treatments, often with limited long-term success.
    • Emerging research suggests that modulating the vaginal microbiome with Lactobacillus strains may offer a promising alternative.
    • A deeper understanding of BV's etiology is needed to develop targeted interventions.

    Conclusions:

    • Effective management of bacterial vaginosis (BV) requires a better understanding of its underlying causes and triggers.
    • Restoring a healthy vaginal microbiome with beneficial bacteria like Lactobacillus is a key area of investigation.
    • Controlling BV may have broader public health implications, potentially reducing risks of preterm birth and HIV acquisition.